Rare diseases
Investigational molecules
Locations
Back to Spain28 clinical trials in Merida, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)A Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
SpainStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
SpainStudy on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)
SpainStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
SpainStudy of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
SpainStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
SpainA study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups
SpainA Study of Inhaled Fexlamose for Adults with Moderate to Severe Chronic Obstructive Pulmonary Disease
SpainStudy of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups
SpainStudy on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems
SpainStudy on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment
SpainStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
SpainThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on systemic lupus erythematosus (SLE) treatments, including trials of novel therapies like dapirolizumab pegol and GLPG3667. These studies aim to evaluate long-term safety and efficacy in managing moderate to severe disease activity.
Additional investigations include innovative treatments for diffuse cutaneous systemic sclerosis and evaluation of deucravacitinib for Sjögren's syndrome patients.
Groundbreaking trials in severe asthma management, particularly focusing on eosinophilic phenotypes. Studies include evaluation of new treatments like GSK3511294 and glycopyrronium for different age groups.
Research extends to chronic obstructive pulmonary disease (COPD), testing medications like astegolimab and itepekimab for exacerbation reduction.
Specialized studies focusing on pediatric respiratory conditions, particularly investigating treatments for children with severe eosinophilic asthma and evaluating lung function improvements.
Clinical trials are evaluating the safety and efficacy of medications specifically designed for young patients aged 6 to 12 years.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
